Literature DB >> 2025172

Mycosis fungoides metastatic to the orbit.

J L Zucker1, M F Doyle.   

Abstract

We report a case of mycosis fungoides metastatic to the anterior orbit in an 83-year-old woman. The patient had a history of several years' duration of well-controlled primary mycosis fungoides with localized dermatologic T-cell lymphomas, mainly on the lower extremities. She developed gradual proptosis, hyperophthalmos, and vertical diplopia. Computed tomography demonstrated a solid, extraconal mass in the right lower anterior orbit. Biopsy revealed a gristly, yellowish, infiltrating mass at the level of the inferior orbital septum. Pathologic examination revealed anaplastic T lymphocytes with multiloculated, cerebriform nuclei that matched those of the primary mycosis fungoides skin tumors. Mycosis fungoides rarely spreads to the ocular and periocular structures, and this case was unique in that it presented as a pure orbital lesion with sparing of the overlying lids and adnexal structures.

Entities:  

Mesh:

Year:  1991        PMID: 2025172     DOI: 10.1001/archopht.1991.01080050102038

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  4 in total

1.  Ocular involvement in mycosis fungoides.

Authors:  R J Leitch; I G Rennie; M A Parsons
Journal:  Br J Ophthalmol       Date:  1993-02       Impact factor: 4.638

2.  Ophthalmic abnormalities in patients with cutaneous T-cell lymphoma.

Authors:  B E Cook; G B Bartley; M R Pittelkow
Journal:  Trans Am Ophthalmol Soc       Date:  1998

3.  Corneal perforation due to limbal involvement in Sézary syndrome.

Authors:  Iain Livingstone; Saraswathi Ramamurthi; Suzannah Drummond; Ewan Kemp; Fiona Roberts
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-01-21       Impact factor: 3.117

Review 4.  Intraocular T-cell lymphoma mimicking a ring melanoma. First manifestation of systemic disease. Report of a case and survey of the literature.

Authors:  O A Jensen; S Johansen; K Kiss
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-03       Impact factor: 3.117

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.